Widder Kenneth J - Apr 27, 2022 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role
Director
Signature
/s/ Matthew J. D'Onofrio, Attorney-in-fact for Kenneth J. Widder
Stock symbol
EVOK
Transactions as of
Apr 27, 2022
Transactions value $
$0
Form type
4
Date filed
4/28/2022, 07:37 PM
Previous filing
May 20, 2021
Next filing
May 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVOK Stock Option (Right to Buy) Award $0 +56K $0.00 56K Apr 27, 2022 Common Stock 56K $0.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant, subject to the reporting person's continued service to the Issuer through such vesting date.